Cogent Biosciences, Inc. (COGT) — Stock Score Summary

Cogent Biosciences, Inc. (COGT) has a MoatMap StockRank of 33/100 based on Quality (32/100), Value (35/100), and Momentum (54/100) factor scores. The current signal is HOLD.

Cogent Biosciences, Inc. is a clinical-stage biotechnology company developing precision therapies for genetically defined diseases, primarily focusing on highly selective kinase inhibitors. Its lead program, bezuclastinib, targets systemic mastocytosis and gastrointestinal stromal tumors, aiming to provide differentiated treatment options for patients with specific genetic mutations.

Key Financial Metrics

Price$32.67
Market Cap$5.6B
P/E (Forward)-33.23
Price/Book9.83
Return on Equity-85.7%
Return on Invested Capital-37.3%
Debt/Equity39.27
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-167M

Cogent Biosciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Cogent Biosciences, Inc.’s (COGT) StockRank?
MoatMap’s StockRank for Cogent Biosciences, Inc. (COGT) is 33/100, with a Hold signal. It is a composite of Quality (32), Value (35), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does Cogent Biosciences, Inc. have an economic moat?
Cogent Biosciences, Inc. (COGT) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cogent Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Cogent Biosciences, Inc. (COGT) is Hold, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cogent Biosciences, Inc. in?
Cogent Biosciences, Inc. (COGT) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksCOGT deep dive reportAI ChampionsHow we score stocksSense-check another stock